Effect of Lactobacillus rhamnosus GG Supplementation on Intestinal Inflammation Assessed by PET/MRI Scans and Gut Microbiota Composition in HIV-Infected Individuals.
- 2018-08-01
- Clinical Trial · n = 45
- Journal of acquired immune deficiency syndromes (1999) 78(4)
- Caroline J Arnbjerg
- Beate Vestad
- Johannes R Hov
- Karin K Pedersen
- Sofie Jespersen
- Helle H Johannesen
- Kristian Holm
- Bente Halvorsen
- Eva Fallentin
- Adam E Hansen
- Theis Lange
- Andreas Kjær
- Marius Trøseid
- Barbara M Fischer
- Susanne D Nielsen
- PubMed: 29874201
- DOI: 10.1097/qai.0000000000001693
- High evidence
- Clinical
No changes were observed for soluble markers of microbial translocation and inflammation (lipopolysaccharide, sCD14, sCD163, sCD25, high-sensitive CRP, IL-6, and tumor necrosis factor-alpha)
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 6 × 10^9 colony-forming units per capsule twice daily